Detalles de la búsqueda
1.
Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma.
Cancer Sci
; 114(3): 1095-1107, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369966
2.
MicroRNA-326 negatively regulates CD155 expression in lung adenocarcinoma.
Cancer Sci
; 114(10): 4101-4113, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37565582
3.
[Kyushu Promotion Plan for the Platform of Human Resource Development for Cancer].
Gan To Kagaku Ryoho
; 49(6): 642-645, 2022 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-35799388
4.
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
Cancer
; 126(1): 219-227, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31503343
5.
Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA.
Oncologist
; 24(8): 1022-1026, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023862
6.
Interleukin-22 attenuates double-stranded RNA-induced upregulation of PD-L1 in airway epithelial cells via a STAT3-dependent mechanism.
Biochem Biophys Res Commun
; 494(1-2): 242-248, 2017 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29032197
7.
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity.
Cancer Discov
; 14(5): 752-765, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227896
8.
Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors.
Cancer Sci
; 104(5): 584-9, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23387505
9.
Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers.
Lung Cancer
; 175: 101-111, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495783
10.
Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1ß.
Front Immunol
; 14: 1192861, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441079
11.
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors.
Lung Cancer
; 181: 107264, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276707
12.
Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L).
JTO Clin Res Rep
; 4(10): 100569, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822699
13.
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer.
Transl Lung Cancer Res
; 11(11): 2208-2215, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519019
14.
Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non-Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L).
Clin Lung Cancer
; 23(3): e257-e263, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34887192
15.
A Randomized Phase II Study Comparing Nivolumab with Carboplatin-Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L).
Clin Cancer Res
; 28(5): 893-902, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921023
16.
Quantification of HER family dimers by proximity ligation assay and its clinical evaluation in non-small cell lung cancer patients treated with osimertinib.
Lung Cancer
; 158: 156-161, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34059353
17.
Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.
Lung Cancer
; 155: 144-150, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33819860
18.
Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis.
Sci Rep
; 11(1): 12732, 2021 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34140559
19.
Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer.
Transl Lung Cancer Res
; 10(6): 2475-2486, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34295655
20.
Pleuropulmonary Paragonimiasis with Multiple Nodules in the Pleura.
Intern Med
; 59(15): 1879-1881, 2020 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32350198